Goldman Sachs' Latest Analysis: Sell Rating on Roche Stock

Monday, 15 July 2024, 12:19

Goldman Sachs maintains its 'Sell' rating on Roche stock with a target price of CHF 230. The analysis focuses on the latest financial performance and market trends, providing insights on potential risks and opportunities for investors. Investors should carefully consider this assessment before making any investment decisions regarding Roche stock.
LivaRava Finance Meta Image
Goldman Sachs' Latest Analysis: Sell Rating on Roche Stock

Goldman Sachs Analysis on Roche Stock

Goldman Sachs, a leading investment bank, has reiterated its 'Sell' rating on Roche stock, recommending caution to investors.

Key Points:

  • Rating: Sell
  • Price Target: CHF 230
  • Recommendation: Exercise caution

Investors are advised to carefully consider Goldman Sachs' analysis before making any investment decisions related to Roche stock.


This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.


Related posts


Newsletter

Get the most reliable and up-to-date financial news with our curated selections. Subscribe to our newsletter for convenient access and enhance your analytical work effortlessly.

Subscribe